Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Dividends
Dividend Yield
Zhejiang Starry Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Zhejiang Starry Pharmaceutical Co Ltd
Zhejiang Starry Pharmaceutical Co Ltd have
decreased
by 0%.
Payout Ratio
Zhejiang Starry Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Zhejiang Starry Pharmaceutical Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Zhejiang Starry Pharmaceutical Co Ltd
| Average Annual Return | -28.23% |
| Standard Deviation of Annual Returns | 25.79% |
| Max Drawdown | -86% |
| Market Capitalization | 4.3B CNY |
| Shares Outstanding | 438 410 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Zhejiang Starry Pharmaceutical Co Ltd's latest stock split occurred on Jun 17, 2022
The company executed a 7-for-5 stock split, meaning that for every 5 shares held, investors received 7 new shares.
Before the split, Zhejiang Starry Pharmaceutical Co Ltd traded at 30.4786 per share. Afterward, the share price was about 30.49.
The adjusted shares began trading on Jun 17, 2022. This was Zhejiang Starry Pharmaceutical Co Ltd's 3rd stock split, following the previous one in Jun 1, 2020.
